Antiemetics: all 820 studies that test it
Page 7 of 9. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.
- Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 YearsWithdrawnNCT01596426Phase 1
- Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 YearsWithdrawnNCT01596413Phase 1
- Pharmacogenetic Treatments for AlcoholismWithdrawnNCT01591291Phase 2/3
- Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy VolunteersCompletedNCT01572012Phase 1
- Use of Prokinetics in Early Enteral Feeding in Preterm InfantsWithdrawnNCT01569633Not applicable
- Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and VomitingCompletedNCT01568268Phase 3
- Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic LaparoscopyCompletedNCT01543945Phase 2
- The Effects of Antihistamines on Pre-Pulse InhibitionCompletedNCT01537471Phase 1
- Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and DexamethasoneStatus unknownNCT01536691Phase 3
- Aprepitant Effects in Intravenous Heroin DependenceCompletedNCT01527994Phase 1
- Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed ConditionsCompletedNCT01523119Not applicable
- Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting ConditionsCompletedNCT01523093Not applicable
- Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain SicknessCompletedNCT01522326Not applicable
- Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed ConditionCompletedNCT01511718Phase 1
- Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting ConditionCompletedNCT01511705Phase 1
- Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and VomitingCompletedNCT01481831Phase 4
- The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency DepartmentStatus unknownNCT01477242Not applicable
- To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult SubjectsCompletedNCT01449188Phase 1
- Aprepitant for Postoperative Nausea and Vomiting in Laparoscopic HysterectomyCompletedNCT01440673Not applicable
- Comparison of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting (PONV) in ChildrenCompletedNCT01434017Phase 4
- Drug Interactions Between Paracetamol and Setrons in Pain ManagementCompletedNCT01432977Phase 3
- Effect of Ramosetron on Bowel Motility After Colorectal ResectionStatus unknownNCT01427127Phase 4
- Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy ParturientsCompletedNCT01414777Phase 2/3
- Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind EyeCompletedNCT01404364Not applicable
- Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving ChemotherapyCompletedNCT01402024Phase 3
- A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water IntakeCompletedNCT01394653Phase 1
- A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional TabletCompletedNCT01392794Phase 1
- The Use of Domperidone for GastroparesisWithdrawnNCT01378884Phase 3
- PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)CompletedNCT01377662Phase 2
- Granisetron Versus Ondansetron: Comparative Effects on ECG, QTcCompletedNCT01352130Phase 4
- Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy AdultsCompletedNCT01347814Not applicable
- Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI TrialCompletedNCT01344304Not applicable
- Ondansetron Augmentation in Treatment-resistant OCDCompletedNCT01303536Phase 4
- Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg DoseCompletedNCT01300988Phase 1
- Pharmacogenetic Factors and Side Effects of Metoclopramide and DiphenhydramineTerminatedNCT01289938Phase 1
- Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive DisorderTerminatedNCT01275248Phase 2
- A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsCompletedNCT01274000Phase 2
- Symptomatic Treatment of Acute GastroenteritisCompletedNCT01257672Phase 3
- Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in AdolescentsTerminatedNCT01249001Phase 2
- A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male PatientsCompletedNCT01225237Phase 4
- Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured PersonsCompletedNCT01222468Phase 2
- Dopaminergic Modulation of Cognition and Psychomotor FunctionCompletedNCT01218425Not applicable
- Scopolamine Challenge StudyCompletedNCT01213355Phase 1
- A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator SicknessStatus unknownNCT01198106Not applicable
- Opioid Effects on Swallowing and Esophageal Sphincter PressureCompletedNCT01191645Phase 4
- Comparison of Adding EMEND to PONV/PDNV Treatment RegimenWithdrawnNCT01186029Not applicable
- Prophylactic Effects of Ondansetron, Ramosetron, and Palonosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Urologic Laparoscopic SurgeryCompletedNCT01169805Not applicable
- Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in SchizophreniaCompletedNCT01121042Phase 3
- Matching Genotypes and Serotonergic Medications for AlcoholismCompletedNCT01113164Phase 1
- Treatment of Chemotherapy-induced Nausea and VomitingCompletedNCT01101529Phase 2
- Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells HarvestingStatus unknownNCT01088022Phase 3
- Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly CisplatinCompletedNCT01074697Phase 3
- Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy SubjectsCompletedNCT01073696Phase 1
- Efficacy and Akathisia Incidence of Slow Infusion MetoclopramideCompletedNCT01069536Not applicable
- Rescue Emetic Therapy for Children Having Elective SurgeryWithdrawnNCT01067677Not applicable
- Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP)CompletedNCT01050270Phase 4
- Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid CancerStatus unknownNCT01046461Phase 2
- Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With ChemotherapyCompletedNCT01046240Phase 1/2
- The Effect of Oral and Intravenous Ramosetron During Laparoscopic CholecystectomyStatus unknownNCT01041183Not applicable
- Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)CompletedNCT01036854Phase 1
- Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic PainStatus unknownNCT01035281Phase 3
- Nabilone & Marijuana AddictionCompletedNCT01025700Phase 2/3
- Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic ChemotherapyCompletedNCT01018758Phase 2
- Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian CancerWithdrawnNCT01017809Not applicable
- Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine SurgeryCompletedNCT01013012Phase 4
- Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)CompletedNCT00981487Phase 1
- Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and VomitingCompletedNCT00971399Phase 3
- Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal RadiotherapyCompletedNCT00970905Phase 2
- The Central Analgesic Effects of Paracetamol on Serotonergic PathwaysCompletedNCT00970450Not applicable
- Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric PatientsCompletedNCT00956215Not applicable
- To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting ConditionsCompletedNCT00947128Phase 1
- To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting ConditionsCompletedNCT00946387Phase 1
- Role of Anti-Inflammatory Agents in Patients With SchizophreniaCompletedNCT00929955Phase 1
- A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT00918411Phase 4
- Late Onset Postoperative Nausea and VomitingCompletedNCT00918190Not applicable
- A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy SubjectsTerminatedNCT00907985Phase 1
- Bioavailability Study of Anti Nausea Medication With and Without FoodCompletedNCT00905190Phase 1
- Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)CompletedNCT00890565Phase 1
- Ondansetron for the Treatment of Heavy Drinking Among Emerging AdultsTerminatedNCT00890149Phase 2
- The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic GastroparesisTerminatedNCT00874133Not applicable
- PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV GranisetronCompletedNCT00873197Phase 1
- Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer PatientsTerminatedNCT00869973Phase 3
- Aprepitant in the Prevention of Cisplatin-induced Delayed EmesisTerminatedNCT00869310Phase 3
- An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal GranisetronCompletedNCT00868764Phase 1
- Dexamethasone for Postoperative Nausea and VomitingCompletedNCT00825071Phase 4
- Efficacy of Dolasetron in Patients With FibromyalgiaCompletedNCT00820326Phase 3
- Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)CompletedNCT00796497Phase 4
- Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon AnaesthesiaCompletedNCT00793663Phase 4
- Prophylactic Dimenhydrinate for Intraoperative Nausea and VomitingCompletedNCT00791960Not applicable
- Uncomplicated Nausea and Vomiting in the Emergency DepartmentCompletedNCT00778011Phase 4
- Domperidone for Refractory Gastrointestinal DisordersStatus unknownNCT00777439Not applicable
- Combined Pharmacotherapies for AlcoholismCompletedNCT00768508Phase 3
- Domperidone for Relief of Gastrointestinal DisordersTerminatedNCT00761254Not applicable
- The Pathophysiology of Orthostatic HypotensionCompletedNCT00748059Phase 1
- Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)CompletedNCT00745004Phase 4
- Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery PatientsCompletedNCT00738621Phase 4
- Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate AbusersStatus unknownNCT00726960Phase 1
- Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast CancerCompletedNCT00719173Phase 1
- Role of Droperidol in Postoperative VomitingCompletedNCT00702442Phase 4
- Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and VomitingWithdrawnNCT00699894Not applicable